Data / Form D filings / Bugworks Research, Inc.
Bugworks Research, Inc.: Form D filings
Bugworks Research, Inc., a biotechnology company in Saratoga, CA, filed 5 Form D notices with the SEC between 2015 and 2024. The latest, on March 8, 2024, reports $6.8 million sold of a $15.8 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13962 Pierce Road, Saratoga, CA, 95070
- Phone
- (818) 230-2227
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1659031
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 8, 2024 | New notice | $15,779,970 | $6,779,976 | $8,999,994 | 15 | Feb 22, 2024 | sec.gov |
| Dec 1, 2021 | New notice | $19,360,834 | $15,974,632 | $3,386,202 | 19 | Nov 16, 2021 | sec.gov |
| Nov 13, 2020 | New notice | $6,249,998 | $6,249,998 | 3 | Apr 3, 2020 | sec.gov | |
| Aug 17, 2018 | New notice | $9,154,865 | $8,454,866 | $699,999 | 13 | Aug 15, 2018 | sec.gov |
| Nov 20, 2015 | New notice | $2,307,381 | $1,607,380 | $700,001 | 7 | Nov 9, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Pradeep Fernandes | Executive Officer | |
| Santanu Datta | Director | |
| Anand Anandkumar | Executive Officer, Director | |
| Tejasvi Ravi | Director | |
| Atsushi Usami | Director | |
| Venkataraman Subramanian | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Mar 4, 2024 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Bugworks Research, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.